Board of Trustees
Professor Mark McCarthy, Wellcome Trust Centre for Human Genetics, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Oxford, UK
Why human genetics? The biological and translational value of research in diabetes genetics.
Professor Hans-Ulrich Haering, Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center, Eberhard-Karls-University, Tuebingen, Germany
Clinical Research Centres of Excellence: the German model
Professor Philippe Halban, Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Novel therapeutic approaches: stem cells
Professor Michaela Diamant, Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands.
Patient involvement in research: how can each person make a difference?
EURADIA Symposium, Lisbon, Portugal, 12 September 2011
Shaping the Future of Research in Europe for the Benefit of People with Diabetes
DIAMAP: a road map for diabetes research in Europe
Professor Philippe Halban, Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland
What can research offer us? Hopes and expectations of people with diabetes
Dr Miriam Cnop, Laboratory of Experimental Medicine, Université Libre de Bruxelles (ULB), Brussels, Belgium.
The political imperative for a European strategy for diabetes
Professor Joao Manuel Valente Nabais, International Diabetes Federation, European Region, Brussels, Belgium
Opportunities to improve infrastructure and the environment to bring innovation to people with diabetes
Professor Cliff Bailey, Aston University, Birmingham
New developments in diabetes treatments: From basic science to care delivery
Thomas Mandrup-Poulsen, University of Copenhagen, Denmark
